Protein palmitoylation is a critical post-translational modification important for membrane compartmentalization, trafficking and regulation of many key signalling proteins. Recent non-radioactive chemo-proteomic labelling methods have enabled a new focus on this emerging regulatory modification. Palmitoylated proteins can now be profiled in complex biological systems by MS for direct annotation and quantification. Based on these analyses, palmitoylation is clearly widespread and broadly influences the function of many cellular pathways. The recent introduction of selective chemical labelling approaches has opened new opportunities to revisit long-held questions about the enzymatic regulation of this widespread posttranslational modification. In the present review, we discuss the impact of new chemical labelling approaches and future challenges for the dynamic global analysis of protein palmitoylation.
Introduction
Protein palmitoylation was first discovered over 30 years ago in classic experiments using tritiated palmitate for metabolic labelling of virus particles and virus-infected cells [1, 2] . Fatty acid modification of viral proteins was shown to be post-translational [3] , covalent [1, 2] and hydroxylamine-sensitive [4] . Further studies demonstrated that this modification occurred on cellular proteins and involved an acyl-thioester linkage to specific cysteine residues [4, 5] . It was quickly evident that palmitoylation is a universal post-translational modification important for the regulation of trafficking, localization and activity of many membrane proteins. Additionally, given the labile properties of the thioester linkage, palmitoylation is potentially reversible and may be regulated in a manner analogous to other widely studied post-translational modifications, such as acetylation, phosphorylation or ubiquination. Until the last few years, the lack of robust enrichment methods prevented a more thorough understanding of palmitoylation and its regulation.
For decades, the only method to detect palmitoylation relied on metabolic incorporation of radioactive palmitate derivates, followed by immunoprecipitation, and long exposures from days to weeks. Using this approach, H-ras depalmitoylation was shown to be accelerated >15-fold on activation [6] . Similarly, G αs palmitoylation turnover is accelerated 50-fold following stimulation [7] . These key findings demonstrated specific signal-dependent depalmitoylation of key signalling proteins involved in cell growth and hormonal signalling, but have left many longstanding questions. First, is the depalmitoylation of key signalling proteins enzymatic? Secondly, which palmitoylated proteins are regulated by depalmitoylating enzymes? Thirdly, what are the enzymes that catalyse palmitoylation and depalmitoylation?
Chemo-proteomic enrichment of palmitoylated proteins
The introduction of new labelling approaches has revolutionized the enrichment, annotation and quantification of protein palmitoylation. The first systematic annotation of palmitoylated proteins was accomplished using an enrichment technique based on selective thioester hydrolysis by hydroxylamine, termed ABE (acyl/biotin exchange) [8] [9] [10] . Free cysteine residues are first alkylated, and then half the sample is treated with hydroxylamine to selectively cleave thioesters. The newly exposed cysteine residues are disulfide-bonded to a biotin analogue, affinity purified and digested into peptides, leaving the labelled peptides on the affinity beads. The eluate is then analysed by MudPIT (multidimensional protein identification technology) using in-line LC-MS (liquid chromatography MS) [11] . The ratio of hydroxylamine-dependent enrichment is used to annotate specific palmitoylated proteins. This method has been widely used to annotate hundreds of palmitoylated proteins from diverse tissues, cells and organisms [9, [12] [13] [14] [15] [16] . Non-specific capture of endogenous stable thioesters, such as acyl carrier proteins and ubiquitin ligases, and incomplete cysteine alkylation reduces the fidelity of the method. More recent modifications of this method introduce a thiol affinity resin to bypass the biotin-streptavidin enrichment [17] , reducing the enrichment steps and eliminating non-specific enrichment of endogenous biotinylated carboxylases. After elution of tryptic peptides, labelled peptides are released by disulfide reduction for LC-MS annotation. This approach allows specific sites of palmitoylation to be inferred. Overall, ABE provides a static profile of palmitoylation without metabolic labelling.
The second enrichment approach uses metabolic labelling with the commercial alkynyl fatty acid analogue 17-ODYA (17-octadecynoic acid) [18] . The cellular palmitoylation machinery readily incorporates 17-ODYA into endogenous sites of palmitoylation within the native cellular environment. After sufficient labelling, the cells are lysed and coupled with azide-linked reporter tags by Cu(I)-catalysed Click chemistry. Palmitoylated proteins are easily detected after rhodamine-azide conjugation for fluorescent gelbased analysis, or selectively enriched after biotin-azide conjugation. This approach has several unique advantages, including temporal control of probe incorporation for pulsechase analysis, and a significant reduction in non-specific labelling. Most importantly, the bioorthogonal approach does not require thiol reduction and alkylation, and small samples can be easily analysed without multiple precipitation steps. This method was first reported using azido-fatty acids [19, 20] , but Click chemistry with alkyne-linked reporters generates significantly higher background labelling [21] . Systematic analysis of the acyl chain-length has shown optimal incorporation of 17-ODYA, whereas shorter chainlengths are better substrates for N-myristoyltransferases [22] . After prolonged incubation, β-oxidation of 17-ODYA generates shorter acyl variants for incorporation into N-myristoylation sites [18] . Probe elongation and β-oxidation can be prevented by incubation with HDYOA (15-hexadecynyloxyacetic acid) [23] , which resists fatty acid remodelling. Several studies have indirectly compared the overlap of 17-ODYA with ABE methods, and the general conclusion is that they both identify a similar profile of palmitoylated proteins, and are best used in combination for orthogonal validation [12] .
Quantitative annotation of palmitoylated proteins
The earliest palmitoylation proteomics studies were qualitatively measured by spectral counting, a semiquantitative method correlated with protein abundance of a limited dynamic range [24] . Spectral counts are assigned as the sum of the number of triggered peptide fragmentations for a specific protein. Ions are analysed by data-dependent acquisition, where the most abundant precursors at a given retention time are selected for ion-trap isolation, fragmentation and low-resolution m/z assignment. Typically, a dynamic exclusion algorithm is included to prevent sequential fragmentation of the same precursor, and to appropriately time a second fragmentation at the apex of the elution profile. Larger wider peaks are fragmented more times than smaller narrower peaks. Spectral count numbers are highly dependent on the length of the protein and the complexity of the sample, and require multiple replicates for statistical significance. For annotating sites of palmitoylation, separate samples are analysed with or without the addition of the enrichment probe, generally with multiple replicates for further validation. The probe-dependent enrichment ratio is then used to assign confidence to the resulting dataset.
Overall, spectral counting is acceptable for comparing large changes from abundant proteins, but is less effective at measuring subtle changes.
These initial studies described the extent of protein palmitoylation in the proteome, but are not sufficiently sensitive to quantitatively compare dynamic palmitoylation events between different cell types or within the same population of cells following perturbation. To achieve this goal, we sought to measure small changes in palmitoylation that may result from temporally or spatially restricted forms of regulation. SILAC (stable isotope-labelling with amino acids in cell culture) is a preferred method for proteome-wide quantification [25] , since complete heavy isotope labelling is achieved metabolically, with no errors associated with in vitro modification. Cells are cultured for several passages in medium supplemented with stable isotopes of lysine and/or arginine. Lysates from perturbed cells grown in a light medium are mixed with lysates from control cells grown in a heavy medium for high-resolution LC-MS analysis. After Click chemistry and enrichment, the samples are digested with trypsin for shotgun proteomics analysis [26] . Importantly, trypsin cleaves at each arginine and lysine residue, leaving a C-terminal isotopic tag with a matching chromatographic retention time. The resulting isotopic SILAC precursor ions are precisely quantified based on the ion current integration across the chromatographic elution peak.
SILAC analysis solves many of the deficiencies of semiquantitative spectral counting. First, each sample has its own internal reference with matching sample preparation, elution time and instrument analysis. Algorithms for peak shape and predicted isotopic distribution provide an additional filter to exclude ions with significant interference. Secondly, the number of replicates is reduced, since the perturbed sample is run at the same time as the internal reference sample. Thirdly, the absolute abundance of each peptide is quantified by the precursor peak area, and matched to the corresponding SILAC isotopic pair. Fourthly, each peptide registers an individual SILAC ratio, which allows calculation of a corresponding standard deviation for each ratio assignment to a specific protein. Finally, reciprocal replicates with inversed isotopic labelling provide a final validation of the selective enrichment, eliminating small variances in expression levels and non-specific enrichment. Altogether, this approach quadruples the number of high confidence palmitoylated proteins annotated in mouse T-cells by reproducibly and accurately quantifying fractional changes in protein enrichment [26] (Figure 1 ).
Proteomic profiling of dynamic palmitoylation
Ras GTPases and G-proteins are rapidly depalmitoylated after stimulation, yet the broader dynamics of palmitoylation have remained largely uncharacterized. Several candidate thioesterases have been identified as able to depalmitoylate protein substrates in vitro [27, 28] or overexpressed substrates in single cells [29, 30] , yet these experiments do not validate the endogenous role of thioesterases in the dynamic turnover of palmitoylation on native proteins. In order to establish the role of thioesterases in dynamic palmitoylation turnover, SILAC proteomics methods and 17-ODYA pulse-chase labelling [31] were used together in two separate experiments to quantitatively profile dynamic palmitoylation in mouse T-cell hybridoma cells [26] (Figure 2 ). In the first experiment, cells were pulsed with 17-ODYA, and exchanged for medium with a 10-fold excess of palmitic acid. Cells were then harvested immediately or after 4 h to profile individual turnover rates. In the second experiment, cells were pulse-labelled with 17-ODYA, and then incubated with or without a nonselective lipase inhibitor for 4 h with excess palmitic acid. This experiment identified palmitoylated proteins that are stabilized by the generic lipase inhibitor HDFP (hexadecyl fluorophosphonate), which targets approximately 20 serine hydrolases in mouse T-cells, but does not inhibit peptidases, proteases or small molecule hydrolases [26] . An unenriched SILAC proteomics experiment was also performed to identify any protein abundance changes occurring during the course of the pulse-chase experiment. Altogether, more than 300 palmitoylated proteins were assayed for accelerated palmitoylation turnover and palmitoylation stabilization by lipase inhibition.
These chemo-proteomics experiments revealed several interesting findings. First, the majority of palmitoylated proteins show relatively stable palmitoylation over the 4-h chase. Of course, this observed stability is relative since there must be a basal level of palmitoylation turnover in the short pulse-labelling time in order to achieve sufficient 17-ODYA labelling. Secondly, a small subset of palmitoylated proteins demonstrated accelerated palmitoylation turnover. This group includes Ras family small GTPases, G-proteins and MAGUK (membraneassociated guanylate kinase) family scaffolding proteins that have all been previously demonstrated to undergo rapid activity-dependent palmitoylation turnover using traditional biochemical methods [6, 7, 32] . This study also identified several other proteins with rapid palmitoylation dynamics, including nucleoporin (Nup210), the metastasis-related protein metadherin (MTDH), the ubiquitin-like modifier Ubl3 and the unannotated protein FAM49b. Thirdly, palmitoylated proteins that are stabilized by lipase inhibition are the same proteins with accelerated palmitoylation turnover. These data validate the role of thioesterases in the dynamic regulation of protein palmitoylation on native proteins, and suggest that HDFP inhibits all of the enzymes capable of regulating dynamic palmitoylation. The candidate thioesterases LYPLA1, LYPLA2 and PPT1 (palmitoyl-protein thioesterase 1) are strongly inhibited by HDFP, although the contribution of other unannotated lipases cannot be excluded. Finally, this experimental approach is ideal for profiling activity-dependent depalmitoylation in other biological contexts.
Figure 2 Experimental approach to profile palmitoylation dynamics
Two separate pulse-chase experiments were designed to identify the palmitoylated proteins with rapid turnover kinetics (Experiment 1), and those stabilized after lipase inhibition (Experiment 2) [26] . Proteomics analysis showed nearly complete overlap in both experiments, signifying the role serine hydrolase family thioesterases in the regulation of the dynamics of palmitoylation.
Palmitoyl acyltransferase substrate annotation
Protein palmitoylation is enzymatic and catalysed by 23 individual PATs (protein acyltransferases), commonly referred to as the DHHC enzyme family owing to the conserved Asp-His-His-Cys catalytic motif [33] . The size of the DHHC enzyme family may explain why no consensus palmitoylation sites have emerged, since each enzyme presumably palmitoylates different substrates. Not surprisingly, PATs localize to different subcellular compartments [34] and have additional domains involved in protein-protein interactions and substrate recognition. Several DHHC PATs have been genetically linked to human diseases, including schizophrenia (DHHC8) [35] , mental retardation (DHHC9 and 15) [36, 37] , Huntington's disease (DHHC17) [38] and cancer (DHHC2, 7, 11, 14 and 20) [39] [40] [41] [42] [43] . Understanding the molecular role of palmitoylation in human disease will require a detailed analysis of the regulation and substrates of each DHHC enzyme.
In order to identify which specific PAT(s) palmitoylate a given protein, each DHHC is separately co-expressed with the candidate substrate and assayed for enhanced substrate palmitoylation. This approach led to the initial identification of four candidate PATs (DHHC2, 3, 7 and 15) that are able to palmitoylate PSD-95 (postsynaptic density protein 95) [33] . Whereas this approach is relatively straightforward, heterologous expression studies may bias towards DHHC enzymes with high expression or that function autonomously. DHHC9 activity, for instance, requires association with GCP16 (GOLGA7; golgin subfamily A member 7) and is inactive when overexpressed alone [44, 45] . Furthermore, many PATs are highly post-translationally modified, suggesting additional levels of regulation. Genetic approaches coupled with proteomic profiling promises a more direct route to annotate DHHC substrates.
The palmitoyltransferase DHHC5 is significantly expressed in the brain, and localizes to the postsynaptic density [46] and dendritic endosomes [47] , suggesting that it may be responsible for palmitoylating synaptic proteins. Mice homozygous for a hypomorphic allele of the ZDHHC5 (zinc finger DHHC-type containing 5) gene are impaired in context-dependent learning and memory, yet the molecular mechanism of this deficiency remains unclear [46] . DHHC5 directly interacts with PSD-95 at the postsynaptic density, but SILAC-labelled wild-type and DHHC5 mutant neuronal stem cells were profiled directly by unenriched proteomics or after 17-ODYA enrichment [48] . Median SILAC ratios of validated palmitoylated proteins observed in both experiments are shown with reference lines signifying two S.D. centred at the mean. The unenriched proteomics experiment is more complex, and hence many palmitoylated proteins were not detected and therefore not shown. Ratios <5 are displayed, which excludes several proteins, including Gjc2, Mydam, Gstk1 and Glb1. Proteins displayed in the upper right-hand quadrant (blue shading) display reduced abundance, which corresponds to reduced 17-ODYA enrichment. Essentially no proteins show a singular reduction in palmitoylation (lower right-hand quadrant, red shading) without a corresponding drop in abundance. These results highlight difficulties in direct annotation of DHHC substrates by proteomic approaches. has no effect on its palmitoylation [46] . DHHC5 clearly plays an important role in synapses, but more advanced approaches were needed to understand its functional role at the synapse.
In order to identify potential substrates of DHHC5, neuronal stem cells were isolated from wild-type and homozygous DHHC5 mutant mice for SILAC isotopic labelling [48] . Heavy and light wild-type cells were labelled with or without 17-ODYA (Experiment 1), and analysed with or without hydroxylamine hydrolysis (Experiment 2). SILAC pairs were mixed, enriched and analysed by MS. Altogether, more than 300 proteins were identified in both experimental groups, as well as several hundred additional proteins only validated in one experimental group. Next, SILAC-labelled wild-type and mutant cells were analysed, revealing approximately 36 dozen candidates with a >2-fold reduction in palmitoylation in DHHC5 mutant cells. This list includes the AMPA (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptor subunit Gria4 (glutamate receptor 4), as well as other neuronal channels, receptors and signalling proteins. To correct the potential changes in protein abundance, unenriched SILAC proteomics experiments were performed in parallel. Surprisingly, essentially all of these palmitoylated proteins demonstrated a corresponding reduction in abundance, suggesting protein palmitoylation may be a critical factor in maintaining protein stability (Figure 3 ). This finding is not surprising, but highlights an inherent biological consequence that will likely emerge in future broad profiling studies. The caveolae-organizing proteins Flot (flotillin) 1 and Flot2 were both identified as potential DHHC5 targets. Interestingly, N-terminally myristoylated Flot2 resists degradation in the absence of DHHC5. Overall, this study annotates hundreds of novel palmitoylated proteins in neuronal stem cells, and demonstrates the unfortunate role of palmitoylation in the stabilization of candidate substrates.
Conclusions
New chemical enrichment methods have greatly accelerated the annotation and analysis of protein palmitoylation. These approaches are critical for moving away from overexpressed substrates and moving towards experiments in native cells. SILAC and other isotopic MS methods facilitate accurate and sensitive profiling across all palmitoylated proteins in biological samples, and will undoubtedly lead to a greater annotation of DHHC substrates and sites of activity-dependent dynamic palmitoylation. A critical future step is to optimize chromatography methods for direct analysis of unmodified palmitoylated peptides, which is fundamentally the best validation for annotating sites of palmitoylation. Altogether, new profiling methods open new opportunities to profile the dynamics of this poorly characterized post-translational modification.
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